array(5) { [0]=> object(WP_Post)#3223 (24) { ["ID"]=> int(94411) ["post_author"]=> string(1) "4" ["post_date"]=> string(19) "2017-12-28 17:51:25" ["post_date_gmt"]=> string(19) "2017-12-29 01:51:25" ["post_content"]=> string(0) "" ["post_title"]=> string(19) "James R. Heath, PhD" ["post_excerpt"]=> string(0) "" ["post_status"]=> string(7) "publish" ["comment_status"]=> string(6) "closed" ["ping_status"]=> string(6) "closed" ["post_password"]=> string(0) "" ["post_name"]=> string(13) "james-r-heath" ["to_ping"]=> string(0) "" ["pinged"]=> string(0) "" ["post_modified"]=> string(19) "2018-08-02 10:41:43" ["post_modified_gmt"]=> string(19) "2018-08-02 17:41:43" ["post_content_filtered"]=> string(0) "" ["post_parent"]=> int(0) ["guid"]=> string(62) "" ["menu_order"]=> int(0) ["post_type"]=> string(10) "isb_people" ["post_mime_type"]=> string(0) "" ["comment_count"]=> string(1) "0" ["filter"]=> string(3) "raw" } [1]=> object(WP_Post)#3222 (24) { ["ID"]=> int(3969) ["post_author"]=> string(2) "26" ["post_date"]=> string(19) "2015-03-30 22:18:10" ["post_date_gmt"]=> string(19) "2015-03-30 22:18:10" ["post_content"]=> string(0) "" ["post_title"]=> string(19) "Leroy Hood, MD, PhD" ["post_excerpt"]=> string(0) "" ["post_status"]=> string(7) "publish" ["comment_status"]=> string(6) "closed" ["ping_status"]=> string(6) "closed" ["post_password"]=> string(0) "" ["post_name"]=> string(10) "leroy-hood" ["to_ping"]=> string(0) "" ["pinged"]=> string(0) "" ["post_modified"]=> string(19) "2018-08-02 10:45:32" ["post_modified_gmt"]=> string(19) "2018-08-02 17:45:32" ["post_content_filtered"]=> string(0) "" ["post_parent"]=> int(0) ["guid"]=> string(61) "" ["menu_order"]=> int(1) ["post_type"]=> string(10) "isb_people" ["post_mime_type"]=> string(0) "" ["comment_count"]=> string(1) "0" ["filter"]=> string(3) "raw" } [2]=> object(WP_Post)#3221 (24) { ["ID"]=> int(3982) ["post_author"]=> string(2) "26" ["post_date"]=> string(19) "2015-03-30 22:24:08" ["post_date_gmt"]=> string(19) "2015-03-30 22:24:08" ["post_content"]=> string(1612) "Over a career encompassing roles in government, nonprofits, and sports, Kathy Scanlan has created a long track record of outstanding results for a broad array of challenging assignments. Kathy likes results. Not just any results, but team achievements that make a measurable difference in other people's lives. Clients value Kathy's ability to get significant, positive outcomes through her dynamic and creative approach to the management of complex projects and partnerships. Kathy consults on a wide variety of interesting assignments. In 1998, Kathy became a partner at Cedar River Group and formed Scanlan Consulting where she has worked with government agencies and nonprofits to facilitate change and help find lasting solutions to what often seemed to be intractable problems. Kathy's consulting assignments have included working closely with the Washington State Legislature on ferry and transportation issues; strategic and business planning for museums, park facilities, and global health/discovery science initiatives; feasibility studies of renewable energy projects; and assisting Washington State cities and counties. For 10 years Kathy was involved in international sports, beginning as Executive Vice-President of the 1990 Seattle Goodwill Games Organizing Committee and ending as President of USA Gymnastics where she helped lead the U.S. to its first women’s gymnastics team gold medal at the 1996 Olympics in Atlanta. Prior to that, Kathy worked for the City of Seattle in finance and parks and her tenure included executive level positions at Seattle Center and Woodland Park Zoo." ["post_title"]=> string(13) "Kathy Scanlan" ["post_excerpt"]=> string(0) "" ["post_status"]=> string(7) "publish" ["comment_status"]=> string(6) "closed" ["ping_status"]=> string(6) "closed" ["post_password"]=> string(0) "" ["post_name"]=> string(13) "kathy-scanlan" ["to_ping"]=> string(0) "" ["pinged"]=> string(0) "" ["post_modified"]=> string(19) "2018-08-02 10:41:08" ["post_modified_gmt"]=> string(19) "2018-08-02 17:41:08" ["post_content_filtered"]=> string(0) "" ["post_parent"]=> int(0) ["guid"]=> string(61) "" ["menu_order"]=> int(10) ["post_type"]=> string(10) "isb_people" ["post_mime_type"]=> string(0) "" ["comment_count"]=> string(1) "0" ["filter"]=> string(3) "raw" } [3]=> object(WP_Post)#3220 (24) { ["ID"]=> int(3974) ["post_author"]=> string(2) "26" ["post_date"]=> string(19) "2015-03-30 22:22:51" ["post_date_gmt"]=> string(19) "2015-03-30 22:22:51" ["post_content"]=> string(1510) "Interaction with the environment is central to how information within our DNA is decoded into observable phenotypes. Dr. Baliga and his laboratory are using a multidisciplinary systems approach to understand this process. Once delineated the engineering principles governing assembly of biological systems will help unlock potentials within diverse organisms. By responsibly using this information we will be able to power spectacular solutions for problems in environment and medicine. Dr. Baliga holds an undergraduate degree in Microbiology from Ruia College, India and a M.Sc. In Marine Biotechnology from Goa University, India. Dr. Baliga conducted his doctoral studies in Microbiology at University of Massachusetts at Amherst and his postdoctoral studies in systems biology with Dr. Leroy Hood at ISB. During his predoctoral studies, he won two competitive awards from the Government of India: the Council for Scientific and Industrial Research Fellowship, and a fellowship from the Department of Biotechnology. Dr. Baliga has also made significant contributions to high school science education throughout Washington. His primary goal is to develop mind stimulating lessons that will prepare a new generation of scientists. Research in Dr. Baliga's laboratory is supported by research grants from the NSF, NIH, NASA and DOE. Learn more about research and education efforts in the Baliga Laboratory by going here." ["post_title"]=> string(25) "Nitin S. Baliga, MSc, PhD" ["post_excerpt"]=> string(0) "" ["post_status"]=> string(7) "publish" ["comment_status"]=> string(6) "closed" ["ping_status"]=> string(6) "closed" ["post_password"]=> string(0) "" ["post_name"]=> string(12) "nitin-baliga" ["to_ping"]=> string(0) "" ["pinged"]=> string(0) "" ["post_modified"]=> string(19) "2018-08-02 10:42:37" ["post_modified_gmt"]=> string(19) "2018-08-02 17:42:37" ["post_content_filtered"]=> string(0) "" ["post_parent"]=> int(0) ["guid"]=> string(61) "" ["menu_order"]=> int(15) ["post_type"]=> string(10) "isb_people" ["post_mime_type"]=> string(0) "" ["comment_count"]=> string(1) "0" ["filter"]=> string(3) "raw" } [4]=> object(WP_Post)#3117 (24) { ["ID"]=> int(3980) ["post_author"]=> string(2) "26" ["post_date"]=> string(19) "2015-03-30 22:23:31" ["post_date_gmt"]=> string(19) "2015-03-30 22:23:31" ["post_content"]=> string(1907) "Nathan Price is the Associate Director of the Institute for Systems Biology. He is also Affiliate Faculty in the Departments of Bioengineering, Computer Science & Engineering, and Molecular & Cellular Biology at the University of Washington.  Prior to joining ISB in 2011, he was an assistant professor at the University of Illinois at Urbana-Champaign, where he maintains adjunct appointments.  Dr. Price has won numerous awards for his work, including an American Cancer Society Postdoctoral Fellowship, a Howard Temin Pathway to Independence Award from the National Institutes of Health (NIH), a National Science Foundation (NSF) CAREER award, a young investigator award from the Roy J. Carver Charitable Trust, being named as one of the inaugural “Tomorrow’s PIs” by Genome Technology, and, most recently, as a Camille Dreyfus Teacher-Scholar. Dr. Price served on the National Academies-Institute of Medicine (IOM) committee to review omics based tests to predict clinical outcome in clinical trials from 2010-2012. Dr. Price served on the scientific advisory board of TetraVitae Bioscience until it was acquired by Eastman Chemical in 2011. He now serves on the Scientific Advisory Boards of Trelys, Inc. and the Novo Nordisk Foundation Center for Biosustainability.  He is also a member of the Board of Directors of the P4 Medicine Institute. He serves on the editorial boards of several scientific journals, including Science Translational MedicineIEEE Life Science LettersBMC Systems Biology, Industrial Biotechnology, and Biotechnology Journal, and was previously a Deputy Editor ofPLOS Computational Biology.     For more information, please see the Price Lab Website:" ["post_title"]=> string(17) "Nathan Price, PhD" ["post_excerpt"]=> string(0) "" ["post_status"]=> string(7) "publish" ["comment_status"]=> string(6) "closed" ["ping_status"]=> string(6) "closed" ["post_password"]=> string(0) "" ["post_name"]=> string(12) "nathan-price" ["to_ping"]=> string(0) "" ["pinged"]=> string(0) "" ["post_modified"]=> string(19) "2018-08-02 10:43:03" ["post_modified_gmt"]=> string(19) "2018-08-02 17:43:03" ["post_content_filtered"]=> string(0) "" ["post_parent"]=> int(0) ["guid"]=> string(61) "" ["menu_order"]=> int(14) ["post_type"]=> string(10) "isb_people" ["post_mime_type"]=> string(0) "" ["comment_count"]=> string(1) "0" ["filter"]=> string(3) "raw" } }
  • James R. Heath, PhD

    President & Professor
  • Leroy Hood, MD, PhD

    SVP and Chief Science Officer, Providence St. Joseph Health; Chief Strategy Officer, Co-founder and Professor, ISB
  • Kathy Scanlan

    Chief Operating Officer
  • Nitin S. Baliga, MSc, PhD

    Senior Vice President, Director and Professor
  • Nathan Price, PhD

    Associate Director and Professor